RESEARCH GOVERNANCE SITE SPECIFIC ASSESSMENT
|
|
- Junior Turner
- 6 years ago
- Views:
Transcription
1 JAN SINGLETON
2 RESEARCH GOVERNANCE SITE SPECIFIC ASSESSMENT
3 Research is what I'm doing when I don't know what I'm doing. ~Wernher Von Braun
4 When are you approved to commence your research? Your study has received a C from ethics = Ethical Clearance Your goal is to obtain A = Approval to commence Obtained only through Governance Authorisation by CE Delegate
5 Why is the Site specific Assessment required? Identify Site Acceptability Financial Accountability & Transparency Identifies Resources Required Identifies Legal requirements & risks No longer requires signatures of all those associated with the research
6 What does it mean when the SSA asks for the following? Site = Metro South Site Description of Study = Plain Language, what the study wants to do at the site, and watch terminology Example Wording dose-ranging study : a clinical trial in which two or more doses of an agent (such as a drug) are tested against each other to determine which dose works best and is least harmful, anyone can understand this wording Principal Investigator & Contact Person = The Investigator at the Site Research will be undertaken, correspondence via the Investigator
7 NEW FORM : Research Contracts and Study Execution Form replaces need for signatures on the SSA Site authority Signature PI s Signature Finance & Department Head Authorisation = Department Head and Finance Manager at the site Mandatory Research Cost Centre = Department Research Cost Centre at the site Mandatory
8 Research Contracts Form Site Contact : Coordinator Metro South Site Authority Signature: QEII/LOGAN/REDLAND etc Principal Investigator: Metro South Investigator/Investigator accessing site Metro South Dept. Head: Signature required Metro South Finance. Head: Signature required Mandatory Metro South Dept. Research Cost Centre: Middle digit is _ or 766 _
9 When is an Agreement needed? Principal/Associate investigators are not employed by Metro South External body wishing to participate in research i.e. Commercial Company, University, Non for Profit Organisation Only the Metro South Chief Executive/Or Delegated person can sign as authority on any given agreement, Governance obtains this signature (make sure Sponsor and PI have signed first)
10 Public Health Act (2005) Approval - Accessing Site Data & Confidential information without Consent Step 1. Ethics Approval with Waiver of Consent Step 2. Metro South Site Data Custodian Approval to access data external institutions only Step 3. Director Generals Approval to release data Step 4. Provide Approval letter to Research Governance Officer
11 Site Specific Documents Multi Site Study HREC approved Master Site Specific Form Tracked version Site Specific Form Clean version How should the Footer Look? Master Form Version 1. 1/1/16 PAH Form Version 1. 2/1/16
12 The Valid SSA SSA & Research Contracts Study execution Form with required Signatures, Cost Centre, supporting paperwork Site Approval i.e QEII, Redland, Logan, Communities etc HREC Approval Letter Quotes: Pathology, Pharmacy, Radiation Quote and report QCAT approval Letter of Risk Benefit for Metro South Sponsored interventional study CV Supporting documentation and Site Specific Forms Agreement PHA Approval Letter Indigenous Elders Support Queensland Forensice & Scientific Services HREC Approval
13 Amendments to the study HREC approval of amendment Addition or deletion of investigators Increase or decrease to the duties or participants Contract amendments Site Specific Documents Contracts Research and Study Execution Form Via Hard copy Reports Annual Report signed by PI Insurance Certificate Commencement Form signed by PI Via
14 Compliance NHMRC National Statement on Ethical Conduct in Human Research2007 NHMRC Universities Australian Code for Responsible conduct of Research 2007 Therapeutic Goods Administration Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95 Public Health Act 2005 (QLD), Part 4 Division 1S280 Guidelines under Section 95 & 95Aof the Privacy Act (Cth) 1988 Information Privacy Act 2009 (Qld) Queensland Intellectual Property Directive, 2013 Queensland Health Research Ethics and Governance Directive, 2013 Finance Management Practice Manual Coroners Act 2003 (Qld) s53 Hospital and Health Boards Act 2011 (Qld) Part 7.
15 Finally!! You have achieved an A Contacts for Governance are: Sonia Hancock : Research Governance Manager ( ) Jan Singleton: Monday to Wednesday Contracts officer Governance ( ) Rhianna Hardie: Thursday/Friday Contracts Officer Governance ( ) PAH-Research@health.qld.gov.au
Author Signature: Date: 10 October 2017 The author is signing to confirm the technical content of this document
SOP Title: Investigator s Brochure Content, Design, Amendments, Filing & Distribution Author: Clinical Research and Development Office (CRDO) Author Signature: Date: 10 October 2017 The author is signing
More informationAuthor Signature: Date: 11 October 2017 The author is signing to confirm the technical content of this document
MELBOURNE CHILDREN S TRIALS CENTRE (MCTC) Guideline document title: Developing, amending and complying with research protocols Version: 2.0 Author: Melbourne Children s Trials Centre (MCTC) Author Signature:
More informationLow/Negligible Risk Research Ethics and Governance Application Guidelines
Low/Negligible Risk Research Ethics and Governance Application Guidelines A human research project cannot commence at a site within Central Adelaide Local Health Network (including Royal Adelaide Hospital
More informationStandard Principles for Operation. National Mutual Acceptance of Single Ethical and Scientific Review of Multi-centre Human Research Projects
Standard Principles for Operation National Mutual Acceptance of Single Ethical and Scientific Review of Multi-centre Human Research Projects Scope These Standard Principles for Operation (Principles) describe
More informationESSENTIAL DOCUMENTS DURING THE CLINICAL CONDUCT OF THE TRIAL
ESSENTIAL DOCUMENTS DURING THE CLINICAL CONDUCT OF THE TRIAL THIS INFORMATION SHEET (ISR-RG-014) HAS BEEN TAKEN DIRECTLY FROM THE ICH- GUIDELINE* WITH ADDITIONAL COMMENTS ADDED BY THE RESEARCH GOVERNANCE
More informationInvestigator Site File Index (CTIMP)
Study Title: Site Name/Number: REC Reference Number: Sponsor Reference Number: EudraCT Number: 1. Protocol Current version plus all previous versions (or provide file note to detail location of previous
More informationThe Victorian Streamlined Review Process and the National Mutual Acceptance (NMA) Streamlined Review Process for Clinical Trials
The Victorian Streamlined Review Process and the National Mutual Acceptance (NMA) Streamlined Review Process for Clinical Trials Angela Henjak, Alfred Health Streamlined Processes: SERP Victorian streamlined
More informationInvestigator Site File Index (Medical Devices)
Study Title: Site Name/Number: REC Reference Number: Sponsor Reference Number: EudraCT Number: 1. Protocol (Clinical Investigation Plan) Current version plus all previous versions (or provide file note
More informationSTANDARD OPERATING PROCEDURE FOR RESEARCH. 14. Amendments to Research Studies
Basildon and Thurrock University Hospitals NHS FT Research & Development APPROVED STANDARD OPERATING PROCEDURE FOR RESEARCH 1. BACKGROUND 14. Amendments to Research Studies Amendments are changes made
More informationStudy Files and Filing
Study Files and Filing The current version of all Hillingdon Hospital R&D Guidance Documents and Standard Operating Procedures are available from the R&D Intranet and Internet sites: www.ths.nhs.uk/departments/research/research.htm
More informationStandard Operating Procedures
Standard Operating Procedures 6.5.1 Study Recruitment Version V2.2 Author/s Approved B Fazekas, S Kochovska D Currow Effective date 28/02/2018 Review date 31/12/2019 DO NOT USE THIS SOP IN PRINTED FORM
More informationOFFICE FOR RESEACH PROCEDURE. Site Initiation and Close-out
OFFICE FOR RESEACH PROCEDURE Site Initiation and Close-out 1. Purpose: To describe the procedures related to site initiation and close-out of a clinical trial. 2. Scope: Applicable to all phases of clinical
More informationPolicy Directive: compliance is mandatory. Research Ethics Operational Policy Directive
Policy Directive: compliance is mandatory Research Ethics Operational Policy Directive Objective file number: 2009-01833 Policy developed by: System Performance Division Approved at Portfolio Executive
More informationROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016
UCLA CTSI WELCOME TO ONLINE TRAINING FOR CLINICAL RESEARCH COORDINATORS ROLE OF THE RESEARCH COORDINATOR Study Startup Best Practices May 2016 Objectives Define the sponsor of a clinical trial and learn
More informationSTANDARD OPERATING PROCEDURE FOR RESEARCH. 17. Study Close Down
Basildon and Thurrock University Hospitals NHS FT Research & Development APPROVED STANDARD OPERATING PROCEDURE FOR RESEARCH 1. BACKGROUND 17. Study Close Down According to ICH Good Clinical Practice (GCP)
More informationApplication form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE
Application form UNIVERSITY OF NOTTINGHAM MEDICAL SCHOOL ETHICS COMMITTEE In completing this form please refer to the attached Notes of Guidance Application for approval of all studies involving Healthy
More informationStandard Operating Procedure. Vendor Management
REFERENCE: VERSION NUMBER: 2.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Clinical Trials Manager, Contracts & Quality Management Officer REVIEWED BY: Research & Innovation Group APPROVED BY:
More informationMelbourne Health Guidelines Cover Sheet
Melbourne Guidelines Cover Sheet NAME OF DEPARTMENT OFFICE FOR RESEARCH NAME OF DOCUMENT Clinical Trials Involving Therapeutic Products and Other Clinical Research NUMBER 18.8 ASSOCIATED MELBOURNE HEALTH
More informationLouise Brook Clinical Trials Quality Monitor. Date
Details: Author: Louise Brook Clinical Trials Quality Monitor SOP Pages: 12 Version No. of replaced SOP: Effective date of replaced SOP: NA NA Approval: Version No: of the SOP being approved. Name of person
More informationSTUDY DOCUMENTS. DOCUMENT NO.: CR007 v4.0. Marise Buçukoğlu ISSUE DATE: 07 MAR 2017 EFFECTIVE DATE: 21 MAR INTRODUCTION
STUDY DOCUMENTS DOCUMENT NO.: CR007 v4.0 AUTHOR: Marise Buçukoğlu ISSUE DATE: 07 MAR 2017 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research & Development (ACCORD) is a joint office
More informationPhase 1 studies and The Over- Volunteering Prevention System (TOPS)
Research Department STANDARD OPERATING PROCEDURE Phase 1 studies and The Over- Volunteering Prevention System () SOP Number C129 Version Number 1.0 Date effective 18 June 2018 Author Luke Barron Related
More informationTrial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products
1 Trial Master File / Investigator Site File Index Clinical Trials of Investigational Medicinal Products SECTION TITLE DOCUMENTS 1. Contact List Including details of relevant study site staff, responsible
More informationSTANDARD OPERATING PROCEDURE SOP 310
STANDARD OPERATING PROCEDURE SOP 310 DEVELOPMENT OF PARTICIPANT INFORMATION SHEET AND INFORMED CONSENT FORM Version 1.3 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 8 Review date April
More informationStandard Operating Procedures (SOPs) to achieve Good Clinical Practice (GCP) in Australian Clinical Research
Standard Operating Procedures (SOPs) to achieve Good Clinical Practice (GCP) in Australian Clinical Research September 2007 Version 1.0 Prepared by Nucleus Network on behalf of VMIA Introduction to the
More informationSTANDARD OPERATING PROCEDURE SOP 410. Set up and Initiation of an Investigator Site
STANDARD OPERATING PROCEDURE SOP 410 Set up and Initiation of an Investigator Site Version 1.2 Version date 4.01.2017 Effective date 5.07.2017 Number of pages 13 Review date July 2019 Author Role NNUH
More informationAustralia: A Dynamic Environment for Conducting Clinical Trials
Australia: A Dynamic Environment for Conducting Clinical Trials MTPConnect s goal is to accelerate the growth of Australia s MTP sector Industry Associations Governments Universities Researchers Investors
More informationRESEARCH AUDIT Standard Operating Procedure
Reference Number: UHB 236 Version Number: 2 Date of Next Review: 17 th Oct 2020 Previous Trust/LHB Reference Number: N/A RESEARCH AUDIT Standard Operating Procedure Introduction and Aim As a legal Sponsor
More informationR&D Administration Manager. Research and Development. Research and Development. NHS Staff Trust-Wide THIS IS A CONTROLLED DOCUMENT
Document Title: Document Number: Research Protocol Design for Papworth Sponsored Studies SOP019 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by:
More informationESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL
Assemble Essential Documents in Trial Master File (TMF) Appendix 1 ESSENTIAL DOCUMENTS FOR THE CONDUCT OF A CLINICAL TRIAL 8.2 Before the Clinical Phase of the Trial Commences During this planning stage
More informationDocument Title: Site Recruitment and Initiation for Papworth Sponsored Studies
Document Title: Site Recruitment and Initiation for Papworth Sponsored Studies Document Number: SOP015 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For
More informationTrial Master File. SOP No. SOP 7
Trial Master File SOP Title Trial Master File SOP No. SOP 7 Author Consultation Departments Date approved Julia Farmery Lincolnshire Clinical Research Facility, Research and Development, Trust consultants
More informationPREPARING TO RUN A TRIAL
PREPARING TO RUN A TRIAL PHASE 1 STUDIES This phase is designed to assess the safety (pharmacovigilance), tolerability, pharmacokinetics, and pharmacodynamics of a drug. STUDY DESIGN Phase I clinical trials
More informationApplying for ethical approval
Applying for ethical approval SOP ID: SOP-Ethics-130304 SOP development and approval SOP developed by Date Associated document(s) 04/03/13 SOP_5.3.1-Ethics-130304-NEAF_FAQ 04/03/13 SOP_5.3.2-Ethics-130304-
More informationSponsorship of Clinical Research Studies
Sponsorship of Clinical Research Studies Category: Summary: Equality Impact Assessment undertaken: Policy The UK Policy Framework for Health and Social Care 2017 (UKPF) and The Medicines for Human Use
More informationScotland A REC 2 nd Floor Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG
Scotland A REC 2 nd Floor Waverley Gate 2-4 Waterloo Place Edinburgh EH1 3EG Telephone: 0131-465-5679 19 February 2016 Professor Karim Brohi Professor of Trauma Science Queen Mary University of London
More informationStandard Operating Procedures
Standard Operating Procedures 6.0 Protocol development History Version Date Author Reason 1.1 10 th Jan 2006 Contributing New procedure authors 1.2 25 th Feb 2007 S Whicker Administrative update 1.3 11
More informationEthics Application Overview
Faculty of Medicine, Dentistry & Health Sciences Melbourne Dental School Ethics Application Overview CONTENTS Prior to an Application... 2 Roles and Responsibilities of student researchers and supervisors
More informationETHICS COMMITTEE. TITLE: Safety Reporting STANDARD OPERATING PROCEDURE SOP006
1 PURPOSE The purpose of this SOP is to describe the Peter MacCallum Cancer Centre (Peter Mac) Ethics Committee process for submission and handling of safety reports arising out of research reviewed by
More informationOFFICE FOR RESEACH PROCEDURE. Sponsor Responsibilities in Investigator Initiated Studies
OFFICE FOR RESEACH PROCEDURE Sponsor Responsibilities in Investigator Initiated Studies 1. Purpose: To define Sponsor Responsibilities in the conduct of Investigator driven studies. 2. Scope: All phases
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Trial Master File & Investigator Site File SOP number: TM 001 SOP category: Trial Management Version number: 03 Version
More informationConducting Clinical Trials of Investigational Medicinal Products
Title: Outcome Statement: Written By: Reviewed By: Conducting Clinical Trials of Investigational Medicinal Products Researchers in the Trust and research partners will be informed about the procedures
More informationSite Initiation and Activation
Site Initiation and Activation Clinical Trials SOP Reference ID: Noclor/Spon/S05/01 Version Number 1.0 Effective Date: 23 rd February 2016 It is the responsibility of all users of this SOP to ensure that
More informationRegulatory and ethical requirements in medical device studies. Finland
Regulatory and ethical in medical device studies Finland SECTIONS A.Type of research SECTIONS A.Type of research We have differentiated 8 types of research: Medical device alone with CE mark use within
More informationNRES Committee East of England - Cambridge Central Royal Standard Place Nottingham NG1 6FS
22 April 2015 NRES Committee East of England - Cambridge Central Royal Standard Place Nottingham NG1 6FS Professor Willem Ouwehand Wellcome Trust Sanger Institute, Honorary NHSBT Consultant in Haematology.
More informationHospital Authority (HA) Guide on Research Ethics (for Study Site & Research Ethics Committee)
Page 1 of 8 Hospital Authority (HA) Guide on Research Ethics (for Study Site & Version Effective Date 2 01/02/2015 Document Number HAHO-CE&TM-HA REC Author HA Head Office Steering Committee on Research
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Essential Documentation and Creation and Maintenance of Trial Master File SOP Number: 13 Version Number: 2.0 Supercedes:
More informationResearch Study Amendments
REFERENCE: VERSION NUMBER: 3.2 EFFECTIVE DATE: 05-02-18 REVIEW DATE: 05-02-20 AUTHOR: Clinical Trials Manager; Clinical Trials Officer REVIEWED BY: R&I Senior Team APPROVED BY: Deputy Director of Research
More informationStandard Operating Procedure
Standard Operating Procedure Number: UM/UoM TMF/SOP08/6.0 Title: The Creation and Maintenance of Trial Master Files and Essential Documentation Version: 6.0 () Effective Date: Author: Mrs Catherine Barrow
More informationSPONSOR INVESTIGATIONAL MEDICINAL PRODUCT (IMP) MANAGEMENT
SPONSOR INVESTIGATIONAL MEDICINAL PRODUCT (IMP) MANAGEMENT DOCUMENT NO.: GS010 v1.0 AUTHOR: Vikki Young ISSUE DATE: 28 MAY 2018 1 INTRODUCTION 1.1 The Academic & Clinical Central Office for Research &
More informationResearch Study Close-down and Archiving Procedures
Title: Research Study Close-down and Archiving Procedures Outcome Statement: To inform researchers of the process for closing down research studies, retaining and storing research materials in the Trust.
More informationInvestigational Medicinal Product (IMP) Management Standard Operating Procedure
Reference Number: UHB 040 Version Number: 3 Date of Next Review: 26 Apr 2019 Previous Trust/LHB Reference Number: T 363 Standard Operating Procedure Introduction and Aim This procedure is written to support
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Training and Development SOP-QMS-007 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s)
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Creation, Review and Management of Standard Operating Procedures for Research SOP Number: 1 Version Number: 2.0 Supercedes:
More informationANZCTR Framework, challenges and immediate future
ANZCTR Framework, challenges and immediate future Professor Lisa Askie ANZCTR Manager Director, Systematic Reviews & Heath Technology Assessment The University of Sydney Page 1 Background and context The
More informationCombined trial of an investigational medicinal product and an investigational medical device
Welcome to the Integrated Research Application System IRAS Project Filter The integrated dataset required for your project will be created from the answers you give to the following questions. The system
More informationGUIDELINES FOR CONDUCTING CLINICAL TRIALS.
GUIDELINES FOR CONDUCTING CLINICAL TRIALS. FOREWORD The purpose of Drug Registration is to ensure that a pharmaceutical product has been adequately tested and evaluated for safety, efficacy and quality,
More informationGuide to EU Clinical Trial Application Form
Deleted: Guide to EU Clinical Trial Application Form SCOPE This user guide has been prepared to help applicants complete the application form to the HPRA for authorisation of a clinical trial
More informationannex 3. Template consent form for biobanking
annex 3. Template consent form for biobanking This template is based on Public Population Project in Genomics and Society (P3G) database resources. General considerations The information brochure and consent
More informationICH GCP Revision and EU Clinical Trial Regulation
ICH GCP Revision and EU Clinical Trial Regulation Sinead Curran, GCP/PhV Inspection Manager Irish Research Nurses Network Annual National Conference Friday, 17 November 2017 Overview Guideline for Good
More informationLOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE. Loughborough University (LU) Research Office
LOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE Loughborough University (LU) Research Office SOP 1024 LU Study Closedown and End of Study Reporting for NHS Research Sponsored by Loughborough
More informationSTANDARD OPERATING PROCEDURE. STH Researcher. Investigator Site File
Research Department STANDARD OPERATING PROCEDURE STH Researcher SOP History CSUH 00/016 SOP Number A116 Created STH Research Department (TL) Reviewed by STH Research Department (AL) 06 August 2009 Superseded
More informationSource Documents and Regulatory Binders October 6, 2016
Source Documents and Regulatory Binders October 6, 2016 Lisa Wilson, Regulatory Lead, Clinical Trials Office and Mark Alger, CRC, Clinical Trials Office Essential Documents AKA: the stuff in the Reg Binder
More informationSetting up new studies where NBT are sponsor
Setting up new studies where NBT are sponsor Task Why Task Should Happen When Task Should Happen Who Should Complete Task How Task is Completed TASK 1: Apply for confirmation that NBT can sponsor the study
More informationDevelopment Safety Update Report Guidance
Development Safety Update Report Guidance This document provides instructions for the preparation and submission of a Development Safety Update Report (DSUR) for a Clinical Trial of an Investigational
More informationA SHORT GUIDE TO THE PROCEDURE FOR A CLINICAL TRIAL APPLICATION IN THE KINGDOM OF BAHRAIN
A SHORT GUIDE TO THE PROCEDURE FOR A CLINICAL TRIAL APPLICATION IN THE KINGDOM OF BAHRAIN Version 1 - June 2017 A Short Guide For CT Application 1 2 A Short Guide For CT Application DEFINITIONS Clinical
More informationAdministrative Policies VMC #638.1 and Procedures Manual
Administrative Policies VMC #638.1 and Procedures Manual January 14, 2013 TO: FROM: SUBJECT: REFERENCE: VMC Employees Paul E. Lorenz Chief Executive Officer, SCVMC Research Involving Human Subjects TJC,
More informationRegulatory Documentation and Submissions for C2012 Clinical Trials DCP SOP #1
Regulatory Documentation and Submissions for C2012 Clinical Trials DCP SOP #1 Phone: 650.691.4400 Fax: 650.691.4410 Email: regulatory.ccsainc.com COMPLIANCE & STANDARDIZATION Rationale for Revision of
More informationDocument Title: Handling of drug alerts and recalls of IMPs
Document Title: Handling of drug alerts and recalls of IMPs Document Number: SOP074 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager,
More informationThe EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Bulgaria Question 1: What laws or regulations apply to an application for conducting a clinical
More informationISRCTN: EudraCT Number: Sponsor Protocol Number: UCL 08/0350. Pharmacy Manual
The StAmP Trial: A Proof of Principle, double blind, Randomised Placebo-Controlled, Multi Centre Trial of Statins to Ameliorate Early Onset Pre-eclampsia. ISRCTN: 23410175 EudraCT Number: 2009-012968-13
More informationPERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES
PERFORMANCE IN INITIATING AND DELIVERING CLINICAL RESEARCH INFORMATION SUBMISSION GUIDELINES Version Control Item 19 Items 25, 26 Item 29 Update to the Publication requirements Update of Submission Timetable
More informationConducting and reporting a GCP Inspection. Gunnar Danielsson Medical Products Agency
Conducting and reporting a GCP Inspection Gunnar Danielsson Medical Products Agency Preparation for an inspection Inspection plan Create worksheets for the inspection general project specific study specific
More informationCompetence in Clinical Trials the Regulators Perspective.. (Jennifer Martin Senior GCP Inspector, 9 June 2014)
Competence in Clinical Trials the Regulators Perspective. (Jennifer Martin Senior GCP Inspector, 9 June 2014) Requirements Statutory Instrument 2004/1031 (as amended) Regulation 28(2): The sponsor (and
More informationInspections: an academic perspective
Inspections: an academic perspective Patricia Henley Quality and Governance Manager Head, Research Governance & Integrity Office London School of Hygiene & Tropical Medicine Email: patricia.henley@lshtm.ac.uk
More informationDate : Date of start of procedure: Authorisation/ positive opinion :
Substantial Amendment Notification Form (Cf. Section 3.7.b of the Detailed guidance on the request to the competent authorities for authorisation of a clinical trial on a medicinal product for human use,
More informationACAP HUMAN RESEARCH Approval and Conduct Guide For students and staff
ACAP HUMAN RESEARCH Approval and Conduct Guide For students and staff ABOUT THIS GUIDE! This Guide outlines the process for applying for and conducting research involving human participants. It should
More information10/9/2012. Alicia Joy, IRB. Wednesday October 10, Please be sure to sign in and take copies of each handout.
Wednesday October 10, 2012 Please be sure to sign in and take copies of each handout. 1 Alicia Joy, IRB 2 FH Office of Research Administration Christina Jackson, BSN, RN, CCRC, CHRC 1 ClinicalTrials.gov
More informationORIGINATION DATE: 01/01/2011 FINAL APPROVAL DATE: April 30, This procedure applies to all clinical trials conducted at any IASIS Facility.
POLICY TITLE: Following the Research Plan MANUAL NAME: Clinical Operations SECTION (as applicable): Clinical Research POLICY NUMBER: CR 1.2.4 Addendum to Corporate Policy Form Available In I-REPP System
More informationPublic Consultation Paper: Assessment of the Functioning of the Clinical Trials Directive 2001/20/EC
Public Consultation Paper: Assessment of the Functioning of the Clinical Trials Directive 2001/20/EC National Institute for Health Research (NIHR CRN) and UKCRC Registered Clinical Trials Units Response
More informationSTANDARD OPERATING PROCEDURE SOP 725 CAPACITY, CAPABILITY AND RISK ASSESSMENT OF TRIALS HOSTED BY NNUH
STANDARD OPERATING PROCEDURE SOP 725 CAPACITY, CAPABILITY AND RISK ASSESSMENT OF TRIALS HOSTED BY NNUH Version 1.0 Version date 13.12.2016 Effective date 13.12.2016 Number of pages 9 pages Review date
More informationStandard Operating Procedure (SOP) for the Development, Management & Control of Research-Related SOPs
Standard Operating Procedure (SOP) for the Development, Management & Control of Research-Related SOPs For Completion by SOP Author Reference Number Version Document Author(s) Document Reviewer(s) PHT/RDSOP/001
More informationCOMMENTS FROM EUROPABIO GENERAL COMMENTS
SUBMISSION OF COMMENTS ON DETAILED GUIDANCE FOR THE REQUEST FOR AUTHORISATION OF A CLINICAL TRIAL ON A MEDICINAL PRODUCT FOR HUMAN USE TO THE COMPETENT AUTHORITIES, NOTIFICATION OF SUBSTANTIAL AMENDMENTS
More informationRDSOP28 Randomisation and Unblinding in Clinical Trials of an Investigational Medicinal Product (CTIMPs)
RDSOP28 Randomisation and Unblinding in Clinical Trials of an Investigational Medicinal Greater Manchester Mental Health NHS Foundation Trust Title of Standard Operating Procedure: Document Summary: Document
More informationISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1
Epidemiologic Research 1 December 12, 2006 Comments on 2006 CIOMS draft Special Ethical Considerations for Epidemiologic Research as proposed supplement to the updated 2002 CIOMS International Ethical
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Maintaining Study Files SOP-RES-014 Version Number 2 Issue Date 08 th Dec 2015 Effective Date 22 nd January 2016 Review Date 22 nd January 2018 Author(s)
More informationResearch Governance Policy and Procedure
Research Governance Policy and Procedure Version: 5 Name of originator/author: Name of executive lead: Date ratified: Review date: APPLICABLE TO: All staff. EXECUTIVE SUMMARY Dr Lisa Austin- University
More informationStandard Operating Procedure
SOP number: Standard Operating Procedure SOP-JRO-015-001 SOP full title: Consent and Sample Tracking for Samples Collected for the Newcastle Biomedicine Research Tissue Bank (REC no. 12/NE/0395) SOP effective:
More informationVersion Number: 004. On: June 2018 Review Date: June 2021 Distribution: Essential Reading for: Information for: Page 1 of 10
Introduction of Novel Therapeutic Interventions Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the agreed policy for the submission
More informationROLE DESCRIPTION. Board Member
ROLE DESCRIPTION Board Member ORGANISATIONAL OVERVIEW AND CONTEXT Developmental Disability Council of WA (trading as Developmental Disability WA) was established in 1985 and is a trusted source of independent
More informationMaintenance Officer Position Description
Maintenance Officer Position Description Position Title: Reports to: Status & Tenure: Classification: Maintenance Officer Business Manager Full Time Continuing School Officer Level 3. Catholic Employing
More informationFDA Sponsor and Investigator Responsibility Checklist
FDA Sponsor and Investigator Responsibility Checklist Principal Investigator: Study Name: CPHS #: IND/IDE #: Name of IND/IDE holder: The following checklist is created based on the Sponsor and Investigator
More informationProtection of Research Participants: The IRB Process and the Winds of Change
Protection of Research Participants: The IRB Process and the Winds of Change Ethics in Patient-Oriented Research October 12, 2011 Sharon Friend Director, OHRPP Overview Charge and Function of the IRB Quick
More informationStandard Operating Procedures
Standard Operating Procedures 8.4.2 Record Destruction Version V2.2 Author/s Approved B Fazekas, S Kochovska D Currow Effective date 28/02/2018 Review date 31/12/2019 DO NOT USE THIS SOP IN PRINTED FORM
More informationCONTINUING PROFESSIONAL DEVELOPMENT POLICY
PARK STREET GROUP PTY LTD POLICY DOCUMENT of 1 January 2019 CONTINUING PROFESSIONAL DEVELOPMENT POLICY CPD Policy Park Street Group Pty Ltd Page 1 Responsibility: 1. Training co-ordinator: Chris Holcombe
More informationStandard Operating Procedures
Standard Operating Procedures 4.7.2 Unblinding Version V2.3 Author/s Approved B Fazekas, S Kochovska D Currow Effective date 28/02/2018 Review date 31/12/2019 DO NOT USE THIS SOP IN PRINTED FORM WITHOUT
More informationThe European Medicines Agency Inspections ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA:
The European Medicines Agency Inspections London, 20 September 2007 EMEA/INS/GCP/197221/2005 Procedure no.: INS/GCP/3/IV ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: SPONSOR
More informationStandard Operating Procedure for Archiving
Standard Operating Procedure for Archiving SOP name: NWORTH07/19 archiving Version 2 Authorship Team: Angela Gliddon & Rhiannon Whitaker Meeting date reviewed 16 th April 2008 Designated NWORTH member
More informationJoint Research Office
Office Location: 1 st Floor Maple House 149 Tottenham Court Road London W1T 7DN Joint Research Office Tel: 020 3447 5557 Fax: 020 3447 9937 Website: www.uclh.nhs.uk; www.ucl.ac.uk; www.ucl.ac.uk/jro Postal
More informationRD SOP32 Gaining MHRA Approval
RD SOP32 Gaining MHRA Approval Version Number: 1.0 Name of originator/author: Dr Lloyd Gregory Name of responsible committee: R&I Committee Name of executive lead: Medical Director & Director of Quality
More information